Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone
- 15 August 2010
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 45 (2) , 136-139
- https://doi.org/10.1016/j.bcmd.2010.05.005
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overloadJournal of Magnetic Resonance Imaging, 2006
- Evaluation of the efficacy of oral deferiprone in β‐thalassemia major by multislice multiecho T2*European Journal of Haematology, 2006
- Purging iron from the heartBritish Journal of Haematology, 2004
- Reversal of cardiac complications in thalassemia major by long‐term intermittent daily intensive iron chelationEuropean Journal of Haematology, 2003
- ALTERNATE USE OF DEFERIPRONE AND DESFERRIOXAMINE IN PRIMARY SCHOOL CHILDREN WITH THALASSAEMIA MAJORBritish Journal of Haematology, 1999
- Combined therapy with deferiprone and desferrioxamineBritish Journal of Haematology, 1998
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJORPublished by Elsevier ,1989
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978